Opioid Sparing Effect of Sphenopalatine Ganglion Block in Functional Endoscopic Sinus Surgery: a Randomized Controlled Clinical Trial.

ConditionSinus Surgery
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-60
SponsorAssiut University

About this trial

Functional endoscopic sinus surgery (FESS) is widely recognized as a safe and preferred treatment option for various conditions, particularly nasal polyps and rhinosinusitis . This technique has been shown to improve postoperative symptoms by 86.3% in patients with chronic inflammatory paranasal sinus diseases .

The aim of this study is to evaluate the effect of adding of MgSO4 to bupivacaine via SPGB block for postoperative pain for 24 hours in patients scheduled for FESS as opioid free anaesthesia.

Eligibility criteria

Qualifiers

• Patients programmed for elective FESS

American society of anaesthesiologists (ASA) physical state I-II

Age over 18 years and less than 60-years-old.

Disqualifiers

• Known hypersensitivity to the study drugs.

Inability to accurately describe postoperative pain to investigators.

Opioid tolerance or dependence.

Patient refusal

Trial design

Treatments tested in this trial

  • Bupivacaine
  • Magnesium Sulphate 500 mg

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators